INTRAVENOUS IMMUNOGLOBULIN TREATMENT INCREASES REGULATORY T CELLS IN HEART RECIPIENTS AFTER ANTI-IL2-RECEPTOR INDUCTION THERAPY

被引：0
|
作者：
Sarmiento, E. [1 ]
Lanio, N. [2 ]
Gallego, A. [1 ]
Palomo, J. [1 ]
Fernandez-Yanez, J. [1 ]
Fernandez-Cruz, E. [1 ]
Carbone, J. [1 ]
机构：
[1] Hosp Gen Gregorio Maranon, Madrid, Spain
[2] Hosp Univ Son Espases, Palma De Mallorca, Spain
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells
    Massoud, Amir H.
    Guay, Julie
    Shalaby, Karim H.
    Bjur, Eva
    Ablona, Aidan
    Chan, Daniel
    Nouhi, Yasaman
    McCusker, Christine T.
    Mourad, M. Walid
    Piccirillo, Ciriaco A.
    Mazer, Bruce D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (06) : 1656 - +
  • [22] Regulatory T cells in rheumatoid arthritis before and after anti-TNF? Therapy
    Ehrenstein, MR
    Evans, J
    Mathews, C
    Choudry, F
    Mauri, C
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 39 - 39
  • [23] T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipients.
    Carreno, MR
    Cirocco, R
    Mathew, J
    Ciancio, G
    Burke, GW
    Miller, J
    Esquenazi, V
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 570 - 570
  • [24] Regulatory T cells control toxicity in a humanized model of IL-2 therapy
    Li, Yan
    Strick-Marchand, Helene
    Lim, Ai Ing
    Ren, Jiazi
    Masse-Ranson, Guillemette
    Li, Dan
    Jouvion, Gregory
    Rogge, Lars
    Lucas, Sophie
    Li, Bin
    Di Santo, James P.
    NATURE COMMUNICATIONS, 2017, 8
  • [25] Regulatory T cells control toxicity in a humanized model of IL-2 therapy
    Yan Li
    Helene Strick-Marchand
    Ai Ing Lim
    Jiazi Ren
    Guillemette Masse-Ranson
    Gregory Dan Li
    Lars Jouvion
    Sophie Rogge
    James P. Lucas
    Nature Communications, 8
  • [26] The Use of Intravenous Immunoglobulin (IVIG) during Severe Neurotoxicity Among the Recipients of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Mokhtari, Sepideh
    Asquith, Justin M.
    Bachmeier, Christina A.
    Jain, Michael D.
    Forsyth, Peter
    Locke, Frederick L.
    Kim, Youngchul
    Lazaryan, Aleksandr
    BLOOD, 2019, 134
  • [27] Influence of an IgM-enriched Intravenous Immunoglobulin-based Treatment on Regulatory T Cells in Patients with Donor Specific Antibodies After Lung Transplantation
    Ius, F.
    Sommer, W.
    Knoefel, A.
    Salman, J.
    Nakagiri, T.
    Siemeni, T.
    Kuehn, C.
    Avsar, M.
    Bobylev, D.
    Poyanmehr, R.
    Welte, T.
    Haverich, A.
    Tudorache, I.
    Warnecke, G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S89 - S89
  • [28] POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER HEART-TRANSPLANTATION ON SANDIMMUNE THERAPY - TREATMENT WITH INTERFERON ALFA-2B AND INTRAVENOUS IMMUNOGLOBULIN
    IPPOLITI, G
    MARTINELLI, L
    LORENZUTTI, F
    INCARDONA, S
    NEGRI, M
    BALDUZZI, P
    ROVATI, B
    ASCARI, E
    VIGANO, M
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2660 - 2661
  • [29] IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation
    Langrehr, JM
    Lohmann, R
    Guckelberger, O
    Müller, AR
    Raakow, R
    Nüssler, NC
    Klupp, J
    Pfitzmann, R
    Jonas, S
    Settmacher, U
    Steinmüller, T
    Neuhaus, P
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1433 - 1434
  • [30] Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections
    Carbone, J.
    Sarmiento, E.
    Del Pozo, N.
    Rodriguez-Molina, J. J.
    Navarro, J.
    Fernandez-Yanez, J.
    Palomo, J.
    Villa, A.
    Munoz, P.
    Fernandez-Cruz, E.
    CLINICAL TRANSPLANTATION, 2012, 26 (03) : E277 - E283
12345